UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus

Arthritis research & therapy, 2016-07, Vol.18 (1), p.162-162, Article 162

2016

Volltextzugriff (PDF)

Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity

Nature immunology, 2020-08, Vol.21 (8), p.950

2020

Volltextzugriff (PDF)

Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development

Gastroenterology (New York, N.Y. 1943), 2022-04, Vol.162 (4), p.1210-1225

2022

Volltextzugriff (PDF)

A Blood-Based Prognostic Liver Secretome Signature Predicts Long-term Risk of Hepatic Decompensation in Cirrhosis

Clinical gastroenterology and hepatology, 2022-05, Vol.20 (5), p.e1188-e1191

2022

Volltextzugriff (PDF)

Exploratory Study of Autoantibody Profiling in Drug‐Induced Liver Injury with an Autoimmune Phenotype

Hepatology communications, 2020-11, Vol.4 (11), p.1651-1663

2020

Volltextzugriff (PDF)

Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress

PloS one, 2013-07, Vol.8 (7), p.e67790

2013

Volltextzugriff (PDF)

Clinical and Immunologic Profiles in Incomplete Lupus Erythematosus and Improvement with Hydroxychloroquine Treatment

Autoimmune Diseases, 2016-01, Vol.2016, p.8791629-9

2016

Volltextzugriff (PDF)

Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis

Clinical gastroenterology and hepatology, 2022-03, Vol.20 (3), p.651-657

2022

Volltextzugriff (PDF)

Hyperactivated PI3Kδ promotes self and commensal reactivity at the expense of optimal humoral immunity

Nature immunology, 2018-09, Vol.19 (9), p.986

2018

Volltextzugriff (PDF)

Plasma-signature-MELD score to predict survival in severe alcoholic hepatitis

Clinical gastroenterology and hepatology, 2021-03, Vol.20 (3), p.651-657

2021

Volltextzugriff (PDF)

Management of hydroxyurea resistant or intolerant polycythemia vera

Leukemia & lymphoma, 2021-08, Vol.62 (10), p.2310-2319

2021

Volltextzugriff (PDF)

1052 PAAM FOR HEPATOCELLULAR CARCINOMA RISK STRATIFICATION IN PATIENTS WITH CIRRHOSIS: MULTICENTER PHASE 3 BIOMARKER VALIDATION STUDIES IN THE U.S

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1563-S-1563

2024

Volltextzugriff (PDF)

Mycobacterium as a contributing cause for anaemia post renal transplant

Pathology, 2018-02, Vol.50, p.S110-S110

2018

Volltextzugriff (PDF)

949: PROGNOSTIC LIVER SECRETOME SIGNATURE AND ALPHA-FETOPROTEIN (PLSEC-AFP) PREDICTS LONG-TERM HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CIRRHOSIS: A NATIONWIDE PHASE 3 BIOMARKER STUDY IN THE U.S

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1140

2022

Volltextzugriff (PDF)

Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells

Journal of allergy and clinical immunology, 2020-02, Vol.145 (2), p.679-697.e5

2020

Volltextzugriff (PDF)

Abstract 2360: Digital spatial profiling of RNA and protein in the tumor microenvironment of invasive lobular breast cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2360-2360

2023

Volltextzugriff (PDF)

Intrathymic AAV gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells

Journal of allergy and clinical immunology, 2019-09, Vol.145 (2), p.679-697.e5

2019

Volltextzugriff (PDF)

Abstract P2-21-08: Digital spatial profiling of RNA and protein in the invasive lobular breast cancer microenvironment

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P2-P2-21-08

2023

Volltextzugriff (PDF)

Peripheral Blood Mononuclear Cell Gene Expression in Chronic Obstructive Pulmonary Disease: miRNA and mRNA Regulation

Journal of inflammation research, 2022-04, Vol.15, p.2167-2180

2022

Volltextzugriff (PDF)

A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis

Med (New York, N.Y. : Online), 2021-07, Vol.2 (7), p.836-850.e10

2021

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(89)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus

Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity

Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development

A Blood-Based Prognostic Liver Secretome Signature Predicts Long-term Risk of Hepatic Decompensation in Cirrhosis

Exploratory Study of Autoantibody Profiling in Drug‐Induced Liver Injury with an Autoimmune Phenotype

Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress

Clinical and Immunologic Profiles in Incomplete Lupus Erythematosus and Improvement with Hydroxychloroquine Treatment

S213: BMS‐986158, A POTENT BET INHIBITOR, AS MONOTHERAPY AND IN COMBINATION WITH RUXOLITINIB OR FEDRATINIB IN INTERMEDIATE‐ OR HIGH‐RISK MYELOFIBROSIS (MF): RESULTS FROM A PHASE 1/2 STUDY

Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis

Hyperactivated PI3Kδ promotes self and commensal reactivity at the expense of optimal humoral immunity

Plasma-signature-MELD score to predict survival in severe alcoholic hepatitis

Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

Management of hydroxyurea resistant or intolerant polycythemia vera

1052 PAAM FOR HEPATOCELLULAR CARCINOMA RISK STRATIFICATION IN PATIENTS WITH CIRRHOSIS: MULTICENTER PHASE 3 BIOMARKER VALIDATION STUDIES IN THE U.S

BMS-986158, a Potent BET Inhibitor, As Monotherapy and in Combination with Ruxolitinib or Fedratinib in Intermediate- or High-Risk Myelofibrosis: First Results from a Phase 1/2 Study

Mycobacterium as a contributing cause for anaemia post renal transplant

949: PROGNOSTIC LIVER SECRETOME SIGNATURE AND ALPHA-FETOPROTEIN (PLSEC-AFP) PREDICTS LONG-TERM HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CIRRHOSIS: A NATIONWIDE PHASE 3 BIOMARKER STUDY IN THE U.S

Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells

Abstract 2360: Digital spatial profiling of RNA and protein in the tumor microenvironment of invasive lobular breast cancer

Intrathymic AAV gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells

Abstract P2-21-08: Digital spatial profiling of RNA and protein in the invasive lobular breast cancer microenvironment

Peripheral Blood Mononuclear Cell Gene Expression in Chronic Obstructive Pulmonary Disease: miRNA and mRNA Regulation

A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis

MPN-381 BMS-986158, a Potent Bromodomain and Extraterminal Domain Inhibitor (BETi), as Monotherapy and in Combination With Ruxolitinib (RUX) or Fedratinib (FED) in Intermediate-Risk or High-Risk Myelofibrosis (MF): Results From a Phase I/II Study

POSTER: MPN-381 BMS-986158, a Potent Bromodomain and Extraterminal Domain Inhibitor (BETi), as Monotherapy and in Combination With Ruxolitinib (RUX) or Fedratinib (FED) in Intermediate-Risk or High-Risk Myelofibrosis (MF): Results From a Phase I/II Study

Suchergebnisse filtern